ISARIC/WHO BIOLOGICAL SAMPLING PROTOCOL www.prognosis.org/isaric Ken Baillie MD PhD, Chair, Genetics, Pathogenesis and Pharmacology Working Group, International.

Slides:

Advertisements

Similar presentations

Public Research Funding in Health Emergencies – Australian Perspective and Strategies Clive Morris Head, Strategic Policy National Health and Medical Research.

Advertisements

Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.

Many Important Issues Covered Current status of ICH E5 and implementation in individual Asian countries Implementation at a regional level (EU) and practical.

1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.

NBSTRN Update NCC/RC PI/PD Meeting November 19, 2010 Michael Watson.

Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.

Role of the laboratory in disease surveillance

Avian Influenza – The Bird Flu

Health System Response to Pandemic Influenza: A Clinician's Perspective Mary M. Klote, MD Walter Reed Army Medical Center.

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical development Phase I Phase II Phase III Product.

Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.

Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.

Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.

International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.

PANDEMIC RISK. 3 pre-requisites for a Pandemic 1. The emergence of a new virus strain with no circulating immunity within the human population 2. The.

Combined thermometer/otoscope device providing dual functionality with no external power source for developing world hospitals Danielle Dorfman.

Objectives: To optimize the delivery of EN by implementing the PEP uP protocol in sites across North America. We provide practitioners the opportunity.

Today, infectious diseases have the potential to spread quickly throughout the world.

Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.

Global Disease Detection India Centre National Centre for Disease Control (Directorate General of Health Services)

Centers for Disease Control and Prevention Program title: Developing sustainable surveillance and response for seasonal and avian influenza. Goal: To establish.

Health Security and Emergencies Ebola Response 13 October 2014.

Can the Application of the International Health Regulations to Antimicrobial Resistance Events Help to Preserve Antimicrobials? AMR 1, abstract N° 406.

Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.

Successful Alerts and Responses: Real-time Monitoring of ED Chief Complaints and Investigation of Anomalies CDC Public Health Preparedness Conference February.

Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.

Morris County Office of Health Management Community Containment for Disease Toolbox NW New Jersey Region.

Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.

Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.

Paula Peyrani, MD Division of Infectious Diseases University of Louisville The IRB Process What do I need to know? The IRB Process.

Pandemic Preparedness Rome | June |1 | Pandemic Preparedness FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian Influenza, June,

1 Division of Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO) Fifth Meeting of National Influenza Centres in the Western.

Public Population Projects in Genomics International Working Groups Working Meeting September th, 2005, Hinxton, UK.

1 April 21 – 23, 2004 Baltimore, Maryland John Arnaldi, Ph.D. Coordinator of Education USF Research Compliance Barry Bercu, M.D. Chair, USF Biomedical.

Wrap-up Day 2. Plenary Four: Pandemic and avian influenza updates Pandemic H1N1 – Origin of pandemic H1N1 virus – Genetically and antigenically homogenous.

Health Security Challenges in The Republic of Macedonia Learning Objectives:  To give background information about health challenges in the country 

Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network

Plans to Assess the Effectiveness of Seasonal and Pandemic Influenza Vaccines during David Shay MD, MPH (Prevention Assessment and Modeling Team.

Preparedness for emerging pathogens: challenges and needs Menno de Jong Department of Medical Microbiology Academic Medical Center, University of Amsterdam.

The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.

Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.

Queen’s University Public Health Informatics (QPHI) Team Can Occupational Health data contribute to Public Health? Tara Donovan Institute.

Session 2: Developing a Comprehensive M&E Work Plan.

NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.

Ethical challenges in research during an epidemic outbreak Krittaecho Siripassorn, MD Chair of the IRB of BIDI Bamrasnaradura Infectious Diseases Institute.

Pandemonium 2008 DOH Full Scale Exercise Danica Mann Healthcare Coalition Training and Exercise Coordinator.

Development of Partnerships:

CLI and Device Intervention Across the Pacific – An FDA View

The PRIME Study Dr. Komalkirti Apte

PhD fellowship in bioinformatics

Infectious Diseases Surveillance in the Military

Case Studies in Big Data and Analysis

Good Clinical Practice

ISARIC – INTERNATIONAL SEVERE ACUTE RESPIRATORY INFECTION CONSORTIUM

The new Way Yaseen Hayajneh, RN, MPH, PhD

بسم الله الرحمن الرحیم.

World Health Organization

Facilitating Routine HIV Testing in Clinical Settings: The Role of the AIDS Education & Training Centers FTCC Meeting- July 14th, 2010 Beth-Anne Jacob,

Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?” Richard Klein, Former Director, FDA.

The role of the OIE in biological threat reduction

The Role of NICs in Influenza Surveillance

Opening an IND: Investigator Perspective

U.S. Influenza Sentinel Provider Surveillance Network

Michael D. Parkins, R. Andres Floto Journal of Cystic Fibrosis

ADVAC ALUMNI MEETING DURING SAGE

PNEUMONIA : A CASE-CONTROL STUDY.

Are we prepared?. Are we prepared? Infectious diseases with epidemic potential A significant public health problem Global health security threat Within.

Katharine James Clinical Neurosciences Research Unit

Multijurisdictional FAQs (Workshop Stream 3)

University of Washington

Presentation transcript:

ISARIC/WHO BIOLOGICAL SAMPLING PROTOCOL Ken Baillie MD PhD, Chair, Genetics, Pathogenesis and Pharmacology Working Group, International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)

The problem Emerging pathogens (MERS CoV, H7N9 influenza, H5N1 influenza) are a major potential threat to global health Cases may be spread across national borders We have to be ready in advance to conduct high-quality observational research

Objectives -Facilitate local research -Make it as easy as possible for local investigators to set up and run independent observational studies -Support research in low- and middle-income countries -Coordinated observational research -Local investigator-led studies from different parts of the world can ultimately be combined to gain more powerful insights into emerging infection -Be ready before the outbreak

Case report forms Minimal case report form Supplementary data forms Intensive data collection forms for first 50 cases worldwide Serial data collection where possible Foundation for biological sampling studies

Biological sampling study criteria Urgency – How urgent is the clinical question? Local cost – How difficult is it to recruit a patient? Requirement for global collaboration – Could a regional/national network do this? Peacetime role – Is this a valid question for a common infection now?

Structure TIER 0: Case report forms only – (ethical approval not required in most jurisdictions) TIER 1: One set of biological samples per patient TIER 2: Serial biological samples TIER 3: Labour-intensive studies STRATIFICATION ACCORDING TO LOCAL RESOURCE REQUIREMENT

Modular protocol

Adaptable to needs/resources

Low sampling intensity low resource OR large number of cases sought

Moderate sampling intensity

High sampling intensity eg. Early in new outbreak, in high-resource setting

Automatically generated protocol Text is added/removed from protocol, information sheets, consent forms according to local needs prognosis.org/isaric

The International Severe Acute Respiratory and Emerging Infection Consortium